Literature DB >> 26560734

Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.

Jeffrey Cui1, Elhamy Heba2, Carolyn Hernandez1, William Haufe2, Jonathan Hooker2, Michael P Andre3,4, Mark A Valasek5, Hamed Aryafar6, Claude B Sirlin2, Rohit Loomba1,7,8.   

Abstract

UNLABELLED: Magnetic resonance elastography (MRE), an advanced magnetic resonance-based imaging technique, and acoustic radiation force impulse (ARFI), an ultrasound-based imaging technique, are accurate for diagnosing nonalcoholic fatty liver disease (NAFLD) fibrosis. However, no head-to-head comparisons between MRE and ARFI for diagnosing NAFLD fibrosis have been performed. We compared MRE versus ARFI head-to-head for diagnosing fibrosis in well-characterized patients with biopsy-proven NAFLD. This cross-sectional analysis of a prospective cohort involved 125 patients (54.4% female) who underwent MRE, ARFI, and contemporaneous liver biopsies scored using the Nonalcoholic Steatohepatitis Clinical Research Network histological scoring system. The performances of MRE versus ARFI for diagnosing fibrosis were evaluated using area under the receiver operating characteristic curves (AUROCs). The mean (± standard deviation) age and body mass index were 48.9 (±15.4) years and 31.8 (±7.0) kg/m(2) , respectively. For diagnosing any fibrosis (≥ stage 1), the MRE AUROC was 0.799 (95% confidence interval [CI] 0.723-0.875), significantly (P = 0.012) higher than the ARFI AUROC of 0.664 (95% CI 0.568-0.760). In stratified analysis by presence or absence of obesity, MRE was superior to ARFI for diagnosing any fibrosis in obese patients (P < 0.001) but not in nonobese patients (P = 0.722). The MRE AUROCs for diagnosing ≥stages 2, 3, and 4 fibrosis were 0.885 (95% CI 0.816-0.953), 0.934 (95% CI 0.863-1.000), and 0.882 (95% CI 0.729-1.000); and the ARFI AUROCs were 0.848 (95% CI 0.776-0.921), 0.896 (95% CI 0.824-0.968), and 0.862 (95% CI 0.721-1.000). MRE had higher AUROCs than ARFI for discriminating dichotomized fibrosis stages at all dichotomization cutoff points, but the AUROC differences decreased as the cutoff points (fibrosis stages) increased.
CONCLUSION: MRE is more accurate than ARFI for diagnosing any fibrosis in NAFLD patients, especially those who are obese.
© 2015 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 26560734      PMCID: PMC4818645          DOI: 10.1002/hep.28337

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

1.  Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging.

Authors:  F Guzmán-Aroca; M D Frutos-Bernal; A Bas; J A Luján-Mompeán; M Reus; Juan de Dios Berná-Serna; P Parrilla
Journal:  Eur Radiol       Date:  2012-06-01       Impact factor: 5.315

2.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

3.  Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.

Authors:  J Cui; B Ang; W Haufe; C Hernandez; E C Verna; C B Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2015-04-15       Impact factor: 8.171

4.  Noninvasive assessment of liver fibrosis using ultrasound-based shear wave measurement and comparison to magnetic resonance elastography.

Authors:  Heng Zhao; Jun Chen; Duane D Meixner; Hua Xie; Vijay Shamdasani; Shiwei Zhou; Jean-Luc Robert; Matthew W Urban; William Sanchez; Matthew R Callstrom; Richard L Ehman; James F Greenleaf; Shigao Chen
Journal:  J Ultrasound Med       Date:  2014-09       Impact factor: 2.153

5.  Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.

Authors:  Ahilan Arulanandan; Brandon Ang; Ricki Bettencourt; Jonathan Hooker; Cynthia Behling; Grace Y Lin; Mark A Valasek; Joachim H Ix; Bernd Schnabl; Claude B Sirlin; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 11.382

6.  The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH.

Authors:  Rohit Loomba; Naga Chalasani
Journal:  Gastroenterology       Date:  2015-06-25       Impact factor: 22.682

7.  Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.

Authors:  Masato Yoneda; Kaori Suzuki; Shingo Kato; Koji Fujita; Yuichi Nozaki; Kunihiro Hosono; Satoru Saito; Atsushi Nakajima
Journal:  Radiology       Date:  2010-06-07       Impact factor: 11.105

8.  Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis.

Authors:  Rohit Loomba; Maria Abraham; Aynur Unalp; Laura Wilson; Joel Lavine; Ed Doo; Nathan M Bass
Journal:  Hepatology       Date:  2012-07-26       Impact factor: 17.425

9.  Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease.

Authors:  Mark L Palmeri; Michael H Wang; Ned C Rouze; Manal F Abdelmalek; Cynthia D Guy; Barry Moser; Anna Mae Diehl; Kathryn R Nightingale
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

10.  Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease.

Authors:  Vincent Wai-Sun Wong; Julien Vergniol; Grace Lai-Hung Wong; Juliette Foucher; Anthony Wing-Hung Chan; Faiza Chermak; Paul Cheung-Lung Choi; Wassil Merrouche; Shirley Ho-Ting Chu; Sophie Pesque; Henry Lik-Yuen Chan; Victor de Lédinghen
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

View more
  65 in total

1.  Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases.

Authors:  Siddharth Singh; Rohit Loomba
Journal:  Hepatology       Date:  2017-11-29       Impact factor: 17.425

Review 2.  Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors:  Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-19       Impact factor: 3.199

Review 3.  Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Authors:  Ken Shirabe; Yuki Bekki; Dolgormaa Gantumur; Kenichiro Araki; Norihiro Ishii; Atsushi Kuno; Hisashi Narimatsu; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2018-01-09       Impact factor: 7.527

4.  A New Multimodel Machine Learning Framework to Improve Hepatic Fibrosis Grading Using Ultrasound Elastography Systems from Different Vendors.

Authors:  Isabelle Durot; Alireza Akhbardeh; Hersh Sagreiya; Andreas M Loening; Daniel L Rubin
Journal:  Ultrasound Med Biol       Date:  2019-10-11       Impact factor: 2.998

5.  Diagnosis of Nonalcoholic Steatohepatitis Without Liver Biopsy.

Authors:  Beatrice L Madrazo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-06

Review 6.  Magnetic resonance elastography: basic principles, technique, and clinical applications in the liver.

Authors:  Habip Eser Akkaya; Ayşe Erden; Diğdem Kuru Öz; Sena Ünal; İlhan Erden
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

7.  Comparison of diagnostic accuracies of two- and three-dimensional MR elastography of the liver.

Authors:  Hiroyuki Morisaka; Utaroh Motosugi; Kevin J Glaser; Shintaro Ichikawa; Richard L Ehman; Katsuhiro Sano; Tomoaki Ichikawa; Hiroshi Onishi
Journal:  J Magn Reson Imaging       Date:  2016-09-23       Impact factor: 4.813

Review 8.  Putting it all together: established and emerging MRI techniques for detecting and measuring liver fibrosis.

Authors:  Suraj D Serai; Andrew T Trout; Alexander Miethke; Eric Diaz; Stavra A Xanthakos; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

9.  High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans.

Authors:  Gordon P Watt; Miryoung Lee; Jen-Jung Pan; Michael B Fallon; Rohit Loomba; Laura Beretta; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-11       Impact factor: 11.382

Review 10.  Magnetic Resonance Elastography of Liver: Current Update.

Authors:  Safa Hoodeshenas; Meng Yin; Sudhakar Kundapur Venkatesh
Journal:  Top Magn Reson Imaging       Date:  2018-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.